mymedschool.orgUSMLE Step 1 Review

USMLE Step 1 Review

Project Types

U01.20.026 Ejection Click
U01.20.025 Holosystolic Murmur
U01.20.024 S4 Heart Sound
U01.20.023 S3 Heart Sound
U01.20.022 Brain Metastases
U01.20.021 Liver Metastases
U01.20.020 Bone Metastases
U01.20.019 Pelvic Inflammatory Disease (PID)
U01.20.018 Bacterial Sexually Transmitted Infection
U01.20.017 Osteomyelitis with Injection Drug Use
U01.20.016 Osteomyelitis in Sickle Cell Disease
U01.20.015 Osteomyelitis
U01.20.014 Bacterial Meningitis (>6 Months Old)
U01.20.013 Bacterial Meningitis (0–6 Months Old)
U01.20.012 Healthcare-Associated Pneumonia (HCAP)
U01.20.011 Food Poisoning
U01.20.010 Viral Infection Secondary to Blood Transfusion
U01.20.009 Viral Encephalitis
U01.20.008 Opportunistic Respiratory Infection in AIDS
U01.20.007 H Pylori
U01.20.006 HLA-DR4
U01.20.005 HLA-DR3
U01.20.004 Lysosomal Storage Disease
U01.20.003 Vitamin Deficiency (USA)
U01.20.002 Intellectual Disability
U01.20.001 Mitochondrial Inheritance
U01.18.029 Gaucher disease
U01.18.028 Tay-Sachs / Niemann-Pick disease
U01.18.027 McArdle disease
U01.18.026 Glycogen storage disease (Cori or von Gierke)
U01.18.025 Alkaptonuria
U01.18.024 Phenylketonuria
U01.18.023 Vitamin K deficiency
U01.18.022 Vitamin D deficiency
U01.18.021 Scurvy
U01.18.020 Vitamin B12 deficiency
U01.18.019 Pantothenic acid deficiency
U01.18.018 Pellagra
U01.18.017 Wet beriberi
U01.18.016 Wernicke-Korsakoff syndrome
U01.18.015 Cri-du-chat syndrome
U01.18.014 Down syndrome
U01.18.013 Edwards syndrome
U01.18.012 Patau syndrome
U01.18.011 Becker muscular dystrophy
U01.18.010 Duchenne muscular dystrophy: Gower sign
U01.18.009 Muscular dystrophy
U01.18.008 Cystic fibrosis
U01.18.007 McCune-Albright syndrome
U01.18.006 Homocystinuria
U01.18.005 Marfan Syndrome
U01.18.004 Ehlers-Danlos Syndrome
U01.18.003 Osteogenesis Imperfecta
U01.18.002 Primary Ciliary Dyskinesia (Kartagener syndrome)
U01.18.001 Lesch-Nyhan syndrome
U01.17.042 Catalase-positive organisms evade killing in CGD
U01.17.041 Type IV hypersensitivity reaction caused by donor T cells attacking host tissues after transplantation
U01.17.040 Candida infections — T-cell and granulocyte deficiencies
U01.17.039 Chronic Granulomatous Disease (CGD)
U01.17.038 Chédiak–Higashi Syndrome
U01.17.037 Leukocyte Adhesion Deficiency (Type I)
U01.17.036 Hyper-IgM Syndrome (CD40L Defect)
U01.17.035 DiGeorge Syndrome (22q11 Deletion Syndrome)
U01.17.034 X-linked (Bruton) Agammaglobulinemia
U01.17.033 Acute hemolytic transfusion reaction
U01.17.032 Type IV Hypersensitivity (T cell–mediated)
U01.17.031 Type III Hypersensitivity (Immune complex-mediated)
U01.17.030 Type II Hypersensitivity (Antibody-mediated)
U01.17.029 Type I Hypersensitivity (IgE-mediated)
U01.17.028 Paroxysmal Nocturnal Hemoglobinuria (PNH)
U01.17.027 Hereditary Angioedema (HAE)
U01.17.026 Terminal complement deficiency (C5–C9)
U01.17.025 Diabetic complications from sorbitol pathway
U01.17.024 Galactokinase Deficiency
U01.17.023 Classic Galactosemia
U01.17.022 Essential Fructosuria
U01.17.021 Hereditary Fructose Intolerance
U01.17.020 Aspirin-induced hyperthermia (mitochondrial uncoupling)
U01.17.019 Alcohol-induced metabolic derangements
U01.17.018 Kwashiorkor
U01.17.017 Pellagra (secondary to carcinoid syndrome)
U01.17.016 Wernicke encephalopathy
U01.17.015 Bitot spots (Vitamin A deficiency)
U01.17.014 Fragile X Syndrome
U01.17.013 Myotonic Dystrophy (DM1)
U01.17.012 Becker Muscular Dystrophy (BMD)
U01.17.011 Duchenne Muscular Dystrophy (DMD)
U01.17.010 Cystic Fibrosis
U01.17.009 Angelman syndrome
U01.17.008 Prader–Willi syndrome
U01.17.007 Marfan syndrome
U01.17.006 Menkes disease
U01.17.005 Ehlers-Danlos syndrome (EDS)
U01.17.004 Osteogenesis imperfecta
U01.13.019 Bipolar disorder
U01.13.018 Hypomanic episode
U01.13.017 Manic episode
U01.13.016 Schizophrenia spectrum disorders
U01.13.015 Mood disorders
U01.13.014 Psycosis